AN3025 nti-PD-1 antibody, supports its further clinical development for the treatment of various human tumors. https://t.co/V9oJ2YO0re https://t.co/hzIEu550g0
78 followers
6 followers
RT @FrontImmunol: New Research: Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity: I…
662 followers
RT @FrontImmunol: New Research: Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity: I…
33,273 followers
New Research: Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity: Infiltration of regulatory T cells (Tregs) in the tumor microenvironment suppresses anti-tumor immune response, and… https://t.co/knlAJ7